Table 2.
Cognition and changes of Aβ between baseline and follow-ups in subjects
| Baseline | Cognitively healthy | Cognitively impaired | ||
| N | 59 | 11 | ||
| Aβ40 | 195 (88) | 201 (60) | ||
| Aβ42 | 50 (121) | 46 (92) | ||
| Aβ42/Aβ40 | 0.236 (0.464) | 0.291 (0.487) | ||
| Cognitively stable or improved | Cognitive decline | |||
| Follow-up | 3 years | 6 years | 3 years | 6 years | 
| N | 43† | 29‡ | 27 | 14 | 
| Change of Aβ40 | 18 (55) | 33 (45) | 21 (24) | 33 (75) | 
| Change of Aβ42 | 3.7 (29) | 12 (54) | 0.0 (14)* | −2.4(50)* | 
| Change of Aβ42/Aβ40 | 0.0093 (0.169) | 0.0166 (0.451) | −0.0027 (0.084)* | −0.0486 (0.251)* | 
Data are given as medians (IQR). The values of p reflect the significance against the cognitively stable subgroup.
p<0.05 against ‘stable or improved.’
Aβ data of one subject is from a plasma sample of 4 years of follow-up.
Cognition data of two subjects is from the previous year.